Volume 58, Issue 3, Pages (September 2000)

Slides:



Advertisements
Similar presentations
Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic Syndrome Marjo Kestilä, Ulla Lenkkeri, Minna Männikkö,
Advertisements

Volume 1, Issue 4, Pages (March 1998)
Volume 359, Issue 9317, Pages (May 2002)
Volume 67, Issue 2, Pages (February 2005)
Structure of the Gene for Congenital Nephrotic Syndrome of the Finnish Type (NPHS1) and Characterization of Mutations  Ulla Lenkkeri, Minna Männikkö,
Induction of Podocyte VEGF164 Overexpression at Different Stages of Development Causes Congenital Nephrosis or Steroid-Resistant Nephrotic Syndrome  Delma.
Volume 80, Issue 7, Pages (October 2011)
Volume 66, Issue 5, Pages (November 2004)
Volume 82, Issue 7, Pages (October 2012)
Inhibition of ILK activity does not affect normal kidney structure and nephrin/ILK interaction in vivo. Inhibition of ILK activity does not affect normal.
Volume 66, Issue 5, Pages (November 2004)
Steroid-resistant nephrotic syndrome
Volume 84, Issue 5, Pages (November 2013)
Volume 82, Issue 7, Pages (October 2012)
Volume 83, Issue 1, Pages (January 2013)
Volume 68, Issue 3, Pages (September 2005)
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Volume 58, Issue 6, Pages (December 2000)
Volume 69, Issue 6, Pages (March 2006)
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Volume 72, Issue 4, Pages (August 2007)
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Mechanisms of the proteinuria induced by Rho GTPases
Volume 79, Issue 12, Pages (June 2011)
Volume 75, Issue 10, Pages (May 2009)
Volume 75, Issue 11, Pages (June 2009)
Volume 66, Issue 3, Pages (September 2004)
A familial childhood-onset relapsing nephrotic syndrome
Volume 59, Issue 5, Pages (May 2001)
Volume 87, Issue 2, Pages (February 2015)
Volume 58, Issue 3, Pages (September 2000)
Volume 1, Issue 4, Pages (March 1998)
Volume 73, Issue 8, Pages (April 2008)
Volume 66, Issue 1, Pages (July 2004)
Volume 70, Issue 8, Pages (October 2006)
Volume 57, Issue 1, Pages (January 2000)
Volume 60, Issue 6, Pages (December 2001)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 54, Issue 2, Pages (August 1998)
Mutations in the AIRE Gene: Effects on Subcellular Location and Transactivation Function of the Autoimmune Polyendocrinopathy-Candidiasis–Ectodermal Dystrophy.
FAT is a component of glomerular slit diaphragms
Volume 66, Issue 1, Pages (July 2004)
Volume 57, Issue 3, Pages (March 2000)
Volume 66, Issue 5, Pages (November 2004)
Volume 67, Issue 4, Pages (April 2005)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Volume 76, Issue 5, Pages (September 2009)
Volume 61, Issue 1, Pages (January 2002)
Volume 72, Issue 3, Pages (August 2007)
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
Volume 68, Issue 2, Pages (August 2005)
Nck Links Nephrin to Actin in Kidney Podocytes
Volume 69, Issue 11, Pages (June 2006)
Mutations in the AIRE Gene: Effects on Subcellular Location and Transactivation Function of the Autoimmune Polyendocrinopathy-Candidiasis–Ectodermal Dystrophy.
Volume 71, Issue 7, Pages (April 2007)
Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome of the Finnish type  Kunihiko Aya, Hiroyuki Tanaka, Yoshiki.
Volume 73, Issue 9, Pages (May 2008)
Direct effects of dexamethasone on human podocytes
Volume 56, Issue 6, Pages (December 1999)
Volume 73, Issue 8, Pages (April 2008)
Volume 57, Issue 4, Pages (April 2000)
Volume 65, Issue 5, Pages (May 2004)
Volume 64, Issue 1, Pages (July 2003)
Volume 65, Issue 6, Pages (June 2004)
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Volume 56, Issue 3, Pages (September 1999)
Volume 85, Issue 4, Pages (April 2014)
Volume 56, Issue 6, Pages (December 1999)
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang,
Volume 57, Issue 1, Pages (January 2000)
Presentation transcript:

Volume 58, Issue 3, Pages 972-980 (September 2000) Congenital nephrotic syndrome (NPHS1): Features resulting from different mutations in Finnish patients  Jaakko Patrakka, Marjo Kestilä, Jorma Wartiovaara, Vesa Ruotsalainen, Päivi Tissari, Ulla Lenkkeri, Minna Männikkö, Ilona Visapää, Christer Holmberg, Juhani Rapola, Karl Tryggvason, Hannu Jalanko  Kidney International  Volume 58, Issue 3, Pages 972-980 (September 2000) DOI: 10.1046/j.1523-1755.2000.00254.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 NPHS1 gene and mutations in Finnish patients.(A)NPHS1 gene. Fin-major mutation is a 2 bp deletion in exon 2, and Fin-minor mutation is a nonsense mutation in exon 26. The three missense mutations are also indicated. (B) Nephrin molecule. Fin-major mutation leads to a truncated protein of 90 amino acids and Fin-minor to a truncated protein of 1109 amino acids. W64S is a change of tryptophan to serine in Ig-1. C465T is a change of cysteine to tyrosine in Ig-5, and R743C is a change of arginine to cysteine in Ig-7. (C) Genotypes of the Finnish NPHS1 patients included in this study. Kidney International 2000 58, 972-980DOI: (10.1046/j.1523-1755.2000.00254.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 In situ hybridization for nephrin mRNA in normal and NPHS1 kidneys. A quite normal signal is seen in kidney glomeruli from patients with Fin-major and Fin-minor mutations. Kidney International 2000 58, 972-980DOI: (10.1046/j.1523-1755.2000.00254.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Immunofluorescence staining for nephrin and ZO-1 in normal and NPHS1 kidneys. No staining of nephrin is seen in NPHS1 glomeruli with different genotypes using polyclonal antibodies against the extracellular part (a-e-nephrin) or intracellular part (a-i-nephrin) of nephrin. The staining pattern of ZO-1 (a-ZO-1) is similar to that of normal kidney in all genotypes. Kidney International 2000 58, 972-980DOI: (10.1046/j.1523-1755.2000.00254.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Western immunoblotting for nephrin in glomerular extracts from normal and NPHS1 kidneys. No expression of nephrin is seen in glomeruli with Fin-major and Fin-minor mutations, as detected by a monoclonal antibody against the extracellular part of nephrin. Kidney International 2000 58, 972-980DOI: (10.1046/j.1523-1755.2000.00254.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Electron microscopy of NPHS1 and control kidneys. (A) The capillary wall in Fin-major homozygote showing podocyte foot processes (arrows) of various size. (B) Filtration slits of various size in the NPHS1 kidney of a Fin-major/Fin-minor genotype. No slit diaphragms are seen. (C) A narrow filtration slit in a NPHS1 kidney of Fin-major homozygote. (D and E) Podocyte filtration slits in normal human kidney. The slit diaphragms are seen as filamentous images (arrows). Kidney International 2000 58, 972-980DOI: (10.1046/j.1523-1755.2000.00254.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Urinary protein excretion and renal findings in NPHS1 patient with Fin-major/R743C mutations. (A) Effect of antiproteinuric therapy on urinary protein excretion. Enalapril and indomethacin were started at the age of three months. The dosing was gradually increased, and two months later (indomethacin 2.2 mg/kg/day and enalapril 1.3 mg/kg/day), a reduction in urinary protein from about 30 g/L to 1 to 3 g/L was observed. After this, prednisone and cyclophosphamide were given for four months and six weeks, respectively, to decrease further the protein excretion. No clear response was observed with either of the drugs. (B) Kidney biopsy was taken at the age of five months (after the decrease of proteinuria), and in immunofluorescence staining, nephrin was expressed normally in the glomeruli. (C) In electron microscopy, fusion of foot processes as well as quite normal-looking foot processes could be seen. Filamentous images of slit diaphragms looked normal between the foot processes (arrows). Kidney International 2000 58, 972-980DOI: (10.1046/j.1523-1755.2000.00254.x) Copyright © 2000 International Society of Nephrology Terms and Conditions